Abbott and Sekisui Collaborate to Offer Coagulation Testing for Laboratories Worldwide

April 14, 2015

ABBOTT PARK, Ill. April 14, 2015/TOKYO, April 15, 2015 — Today, Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots.  

Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark. 

Click here for complete press release

« Return to news list